Abstract 239P
Background
Oral cancer surgery includes radical resections of the mandible and tongue, affecting the functional swallowing outcomes. However, risk factors and swallowing outcomes are not the same for all subsites of oral cancer. The present study aimed to assess the difference in patient-reported swallowing function and quality of life after primary surgical resection in tongue vs bucco- alveolar complex (BAC) malignancies.
Methods
Study included oral cancer patients requiring mandibulectomy for BAC subsite and at least hemi-glossectomy for tongue, all reconstructed with pedicle flaps at our institute from Dec 2019 to Dec 2021. The Sydney Swallow Questionnaire (SSQ) and Functional oral intake scale (FOIS) were used to assess swallowing outcomes after six months DFS. WHO BREF questionnaire was used to assess health-related quality of life.
Results
The final analysis included 66 patients. The median age was 48 yrs and majority are males (92.4%). BAC constituted 63.6%, and tongue lesions were 36.4%. Tumours with cT3 and T4 are 59% of BAC and 46% of tongue lesions. In BAC, 85% underwent segmental mandibulectomy, and 87% of tongue lesions were treated with hemiglossectomy. 85.7% of BAC and 92% of tongue lesions received adjuvant radiation. Trismus and xerostomia were present in 71.4%, 85% in BAC and 50%, 75% in tongue lesions, respectively. The mean SSQ score was (282.6, SD= 95), (222.5, SD=96) BAC and tongue, respectively. Advanced T stage (p=0.07), Multimodality treatment (p=0.01), lymphedema (p=0.03), Trismus (p=0.01), Dysgeusia (p=0.01), xerostomia (p=0.01) in BAC lesions. Advanced T stage (p=0.007), Multimodality treatment (p=0.04), lymphedema (p=0.03), Dysgeusia (p=0.01) in tongue lesions are associated with poor outcomes. Almost 88% of BAC lesions required special food preparation for swallowing (FOIS 5). However, only 16.7% of tongue lesions required special preparation. There is a trend toward better health-related quality of life (HRQOL) in tongue lesions.
Conclusions
There is a difference in swallowing results between tongue and BAC cancers. Tongue lesions had more reasonable swallowing outcomes. However, overall, HRQOL is comparable between both subsites.
Clinical trial identification
Editorial acknowledgement
Legal entity responsible for the study
The authors.
Funding
Has not received any funding.
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
247TiP - Addition of induction, concurrent and maintenance durvalumab to induction and concurrent chemoradiation vs induction and concurrent chemoradiation for previously untreated locoregionally advanced nasopharyngeal carcinoma: A phase II randomised-controlled trial
Presenter: Victor Lee
Session: Poster viewing 03
248P - The use of complementary medicine in Chinese pediatric patients receiving palliative care: A multi-centre study
Presenter: Chun SIng Lam
Session: Poster viewing 03
249P - Improving quality of life and symptom burden with opioids and adjuncts in lung cancer (IQSOL study)
Presenter: Naren Gokulanathan
Session: Poster viewing 03
250P - An analysis of nutritional and psychological status of patients with advanced cancer
Presenter: Shasha Wang
Session: Poster viewing 03
251P - Is QUAD SHOT palliative cyclical hypo-fractionated radiotherapy in advanced head and neck cancer the way to go? An alternative regimen in low resource countries
Presenter: Ravi Kanodia
Session: Poster viewing 03
252P - Preferred place of death among terminally ill cancer patients: A single centre observational study from India
Presenter: Suhana Sulfiker
Session: Poster viewing 03
253P - Hemostatic radiotherapy for gastric cancer: MRI as an alternative to endoscopy for post-treatment evaluation
Presenter: Osamu Tanaka
Session: Poster viewing 03
254P - Sexual function of cervical cancer survivors: A single center prospective study
Presenter: Dinesh Ravikumar
Session: Poster viewing 03
255P - Volunteers’ role to provide quality palliative care for terminal cancer
Presenter: SAPTAPARNA JANA
Session: Poster viewing 03